المؤلفون: Rogliani, Paola, Ora, Josuel, Matera, Maria Gabriella, Cazzola, Mario, Calzetta, Luigino

المصدر: Expert Opinion on Drug Safety; June 2018, Vol. 17 Issue: 6 p589-596, 8p

المؤلفون: Matera, Maria Gabriella, Calzetta, Luigino, Puxeddu, Ermanno, Rogliani, Paola, Cazzola, Mario

المصدر: Expert Opinion on Drug Safety; May 2018, Vol. 17 Issue: 5 p509-517, 9p

المؤلفون: Rogliani, Paola, Calzetta, Luigino, Cazzola, Mario, Matera, Maria Gabriella

المصدر: Expert Opinion on Drug Safety; August 2016, Vol. 15 Issue: 8 p1133-1146, 14p

المؤلفون: Cazzola, Mario, Calzetta, Luigino, Matera, Maria Gabriella

المصدر: Expert Opinion on Drug Safety; January 2010, Vol. 9 Issue: 5 p783-792, 10p

المؤلفون: Maria Gabriella Matera, Luigino Calzetta, Paola Rogliani, Mario Cazzola

المساهمون: Rogliani, Paola, Calzetta, Luigino, Cazzola, Mario, Matera, Maria Gabriella

المصدر: Expert opinion on drug safety. 15(8)

مصطلحات موضوعية: Drug, safety, Cyclopropanes, medicine.medical_specialty, Gastrointestinal Diseases, media_common.quotation_subject, Settore MED/10 - Malattie dell'Apparato Respiratorio, adverse event, Aminopyridines, Pharmacology, Placebo, meta-analysi, Medication Adherence, Rofllumilast, 03 medical and health sciences, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Internal medicine, medicine, Humans, Pharmacology (medical), Adverse effect, Roflumilast, media_common, Randomized Controlled Trials as Topic, COPD, business.industry, PDE4 inhibitor, General Medicine, medicine.disease, adverse events, meta-analysis, Chronic cough, Treatment Outcome, 030228 respiratory system, 030220 oncology & carcinogenesis, Meta-analysis, Benzamides, Sputum, Drug Therapy, Combination, Phosphodiesterase 4 Inhibitors, medicine.symptom, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d719daec056659da75d16e25254094aTest
https://pubmed.ncbi.nlm.nih.gov/27279341Test